Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.
2.

Impact of the 2014 International Society of Urological Pathology Grading System on Concept of High-Risk Prostate Cancer: Comparison of Long-Term Oncological Outcomes in Patients Undergoing Radical Prostatectomy.

Milonas D, Venclovas Ž, Gudinaviciene I, Auskalnis S, Zviniene K, Jurkiene N, Basevicius A, Patasius A, Jievaltas M, Joniau S.

Front Oncol. 2019 Nov 19;9:1272. doi: 10.3389/fonc.2019.01272. eCollection 2019.

3.

Age and aggressiveness of prostate cancer: analysis of clinical and pathological characteristics after radical prostatectomy for men with localized prostate cancer.

Milonas D, Venclovas Z, Jievaltas M.

Cent European J Urol. 2019;72(3):240-246. doi: 10.5173/ceju.2019.1974. Epub 2019 Sep 16.

4.

A Population-Based Analysis of Incidence, Mortality, and Survival in Testicular Cancer Patients in Lithuania.

Drevinskaite M, Patasius A, Kincius M, Jievaltas M, Smailyte G.

Medicina (Kaunas). 2019 Aug 30;55(9). pii: E552. doi: 10.3390/medicina55090552.

5.

A phase 3, open-label, multicenter study of a 6-month pre-mixed depot formulation of leuprolide mesylate in advanced prostate cancer patients.

Shore N, Mincik I, DeGuenther M, Student V Jr, Jievaltas M, Patockova J, Simpson K, Hu CH, Huang ST, Li Y, Lee Y, Chien B, Mao J.

World J Urol. 2020 Jan;38(1):111-119. doi: 10.1007/s00345-019-02741-7. Epub 2019 Apr 3.

PMID:
30941562
6.

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.

Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators.

N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14.

PMID:
30763142
7.

Caffeic Acid Phenethyl Ester Reduces Ischemia-Induced Kidney Mitochondrial Injury in Rats.

Trumbeckaite S, Pauziene N, Trumbeckas D, Jievaltas M, Baniene R.

Oxid Med Cell Longev. 2017;2017:1697018. doi: 10.1155/2017/1697018. Epub 2017 Aug 13.

8.

Factors influencing renal graft survival: 7-Year experience of a single center.

Auglienė R, Dalinkevičienė E, Kuzminskis V, Jievaltas M, Peleckaitė L, Gryguc A, Stankevičius E, Bumblytė IA.

Medicina (Kaunas). 2017;53(4):224-232. doi: 10.1016/j.medici.2017.07.003. Epub 2017 Jul 29.

9.

Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial.

Milonas D, Auskalnis S, Skulcius G, Gudinaviciene I, Jievaltas M, Joniau S.

World J Urol. 2017 May;35(5):721-728. doi: 10.1007/s00345-016-1938-8. Epub 2016 Sep 19.

PMID:
27644229
10.

Evaluation of LRINEC Scale Feasibility for Predicting Outcomes of Fournier Gangrene.

Kincius M, Telksnys T, Trumbeckas D, Jievaltas M, Milonas D.

Surg Infect (Larchmt). 2016 Aug;17(4):448-53. doi: 10.1089/sur.2015.076. Epub 2016 Mar 29.

PMID:
27023717
11.

Short ischemia induces rat kidney mitochondria dysfunction.

Baniene R, Trumbeckas D, Kincius M, Pauziene N, Raudone L, Jievaltas M, Trumbeckaite S.

J Bioenerg Biomembr. 2016 Feb;48(1):77-85. doi: 10.1007/s10863-016-9643-2. Epub 2016 Jan 18.

PMID:
26782060
12.

The effect of complete transurethral resection of the prostate on symptoms, quality of life, and voiding function improvement.

Milonas D, Verikaite J, Jievaltas M.

Cent European J Urol. 2015;68(2):169-74. doi: 10.5173/ceju.2015.507. Epub 2015 Mar 31.

13.

Evaluation of urinary prostate cancer antigen-3 (PCA3) and TMPRSS2-ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancer.

Martínez-Piñeiro L, Schalken JA, Cabri P, Maisonobe P, de la Taille A; Triptocare Study Group.

BJU Int. 2014 Oct;114(4):608-16. doi: 10.1111/bju.12542. Epub 2014 Apr 4.

14.

Evaluation of D'Amico criteria for low-risk prostate cancer.

Milonas D, Kinčius M, Skulčius G, Matjošaitis AJ, GudinavičienĖ I, Jievaltas M.

Scand J Urol. 2014 Aug;48(4):344-9. doi: 10.3109/21681805.2013.870602. Epub 2014 Feb 12.

PMID:
24521187
15.

Does illness perception explain quality of life of patients with prostate cancer?

Mickevičienė A, Vanagas G, Jievaltas M, Ulys A.

Medicina (Kaunas). 2013;49(5):235-41.

16.

Comparison of long-term results after nephron-sparing surgery and radical nephrectomy in treating 4- to 7-cm renal cell carcinoma.

Milonas D, Skulčius G, Baltrimavičius R, Auškalnis S, Kinčius M, Matjošaitis A, Gudinavičienė I, Smailytė G, Jievaltas M.

Medicina (Kaunas). 2013;49(5):223-8.

17.

Development of a short questionnaire to identify the risk of nonadherence to antibiotic treatment.

Kandrotaite K, Smigelskas K, Janusauskiene D, Jievaltas M, Maciulaitis R, Briedis V.

Curr Med Res Opin. 2013 Nov;29(11):1555-63. doi: 10.1185/03007995.2013.835255. Epub 2013 Sep 11.

PMID:
23952367
18.

Simultaneous nephrectomy and coronary artery bypass grafting through extended sternotomy.

Budrikis A, Jievaltas M, Al Assaad S, Kinduris S.

J Cardiothorac Surg. 2012 Aug 30;7:79. doi: 10.1186/1749-8090-7-79.

19.

Factors affecting health-related quality of life in prostate cancer patients.

Mickevičienė A, Vanagas G, Ulys A, Jievaltas M, Smailytė G, Padaiga Ž.

Scand J Urol Nephrol. 2012 Jun;46(3):180-7. doi: 10.3109/00365599.2012.661765. Epub 2012 Mar 1.

PMID:
22375530
20.

Survival of patients with testicular cancer in Lithuania during 1999-2002.

Juška A, Ulys A, Kairevičė L, Smailytė G, Stankevičius E, Jančiauskienė R, Jievaltas M.

Medicina (Kaunas). 2011;47(1):52-6.

Supplemental Content

Loading ...
Support Center